1 / 1
Gilteritinib(Xospata)
Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection
Reference price:
Manufacturer:
Astellas Pharma Inc
Formulation:
TABLET
Validity period:
24 months
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of
a
pharmacist. For read by medical and pharmaceutical professionals only.
Gilteritinib(Xospata) Instructions:Uses,Dosage, Side Effects
XOSPATA, with the generic name gilteritinib, is an oral kinase inhibitor developed for the treatment of acute myeloid leukemia. It is specifically designed to target and inhibit the FMS-like tyrosine kinase 3 (FLT3) receptor, which is a key driver of disease progression in a specific genetic subset of AML. The drug is formulated as a 40 mg film-coated tablet for once-daily administration.
